Osi Pharmaceuticals, Inc.

Ti Wang

Jing Wang

Hanqing Dong

An-Hu Li

Mark Joseph Mulvihill

Meizhong Jin

Xin Chen

Arno G Steinig

Qinghua Weng

Andrew Kleinberg

Furo[3,2-c]Pyridine and Thieno[3,2-c]pyridine compounds of Formula I, and pharmaceutically acceptable salts thereof, preparation, intermediates, pharmaceutical compositions, and use, such as in disease treatment, including cancers, including conditions in which EMT is involved, including conditions mediated by protein kinase activity such as RON and/or MET. 

Furo[3,2-C]pyridines

Growing community of inventors

Evanston, IL, United States of America

Ti Wang